Skip to Content

Improved PFS and OS in HER2-Positive and Triple-Negative Breast Cancer

/ Hanne Melgaard Nielsen / Jan Andreasen

First-Line Lorlatinib in ALK-Positive NSCLC

/ Jon Alexander Lykkegaard Andersen

Testing New Therapies for Ovarian Cancer in a 3D Model

/ Christiane Helgestad Gjerde / Katrin Kleinmanns / Emmet McCormack / Line Bjørge

Patient monitoring and decision-making in CIDP

/ Lars Kjøbsted Markvardsen / Jan Andreasen
Back to top